Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

LRLRMR
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in LARIMAR THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 1.8M shares of LRMR (LARIMAR THERAPEUTICS INC), worth $5.3M as of 2026-Q2. The position was increased (+12.3% shares). LRMR represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$5.3M

Current Shares

1.8M

Total Value Change

-$10.7M

Total Shares Change

-2.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.8M
+12.3%
$5.3M0.0%$3.05
30
2026-Q1
Increased
1.6M
+15.9%
$7M0.0%$5.51
32
2025-Q4
Decreased
1.3M
-14.5%
$5.1M0.0%$3.91
0
2025-Q3
Increased
1.6M
+1096.6%
$5.1M0.0%$3.38
43
2025-Q2
Decreased
131,622
-95.1%
$380,3870.0%$3.03
0
2025-Q1
Decreased
2.7M
-35.7%
$5.7M0.0%$2.35
0
2024-Q4
New
4.2M
-
$16.1M0.0%$3.91
39

Other major holders of LRMR: RA CAPITAL MANAGEMENT, L.P., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used